Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Pattison

Showing results (21-30 of 71) with videos related to

Pageof 8
Sort By:
Internal Medicine Journal|January 10, 2018
Localisation of occult extra-pancreatic insulinoma using glucagon-like peptide-1 receptor molecular imagingAnna K Mossman, David A Pattison, Rodney J Hicks, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 14, 2017
<sup>18</sup>F-FDG-Avid Thyroid Incidentalomas: The Importance of Contextual InterpretationDavid A Pattison, Michael Bozin, Alexandra Gorelik, et al.
Journal of Medical Imaging and Radiation Oncology|May 5, 2026
Assessing Correlation of Quantitative Technetium-99m Sestamibi Uptake in Thyroid Scintigraphy With Treatment Duration in Amiodarone-Induced ThyrotoxicosisRay Wang, Nathan Better, Dinesh Sivaratnam, et al.
EJNMMI Research|February 10, 2019
Personalised insulin calculator enables safe and effective correction of hyperglycaemia prior to FDG PET/CTDavid A Pattison, Lisa L MacFarlane, Jason Callahan, et al.
Clinical Nuclear Medicine|July 14, 2022
99m Tc-Sestamibi Thyroid Scintigraphy in Amiodarone-Induced Thyrotoxicosis : Functional Imaging-Histopathologic CorrelationRay Wang, Nathan Better, Dinesh Sivaratnam, et al.
Internal Medicine Journal|December 14, 2020
Utility of <sup>68</sup> Ga-DOTA-Exendin-4 positron emission tomography-computed tomography imaging in distinguishing between insulinoma and nesidioblastosis in patients with confirmed endogenous hyperinsulinaemic hypoglycaemiaVictor Kalff, Amir Iravani, Timothy Akhurst, et al.
Journal of Critical Care|September 15, 2020
Octreotide for resuscitation of cardiac arrest due to carcinoid crisis precipitated by novel peptide receptor radionuclide therapy (PRRT): A case reportJayesh Dhanani, David A Pattison, Matthew Burge, et al.
Nuclear Medicine Communications|January 9, 2015
Quantitative assessment of thyroid-to-background ratio improves the interobserver reliability of technetium-99m sestamibi thyroid scintigraphy for investigation of amiodarone-induced thyrotoxicosisDavid A Pattison, James Westcott, Meir Lichtenstein, et al.
Clinical Case Reports|April 12, 2018
Diagnostic challenges in a patient with an occult insulinoma:<sup>68 </sup>Ga-DOTA-exendin-4 PET/CT and <sup>68</sup>Ga-DOTATATE PET/CTElisa Bongetti, Melissa H Lee, David A Pattison, et al.
Bone Marrow Transplantation|January 23, 2022
[<sup>18</sup>F]GE-180 PET/CT assessment of enterocytic translocator protein (TSPO) over-expression: a pilot study in gastrointestinal GVHDAshleigh P Scott, Paul Thomas, David A Pattison, et al.
Pageof 8

Showing results (21-30 of 71) with videos related to

Sort By:
Pageof 8
Internal Medicine Journal|January 10, 2018
Localisation of occult extra-pancreatic insulinoma using glucagon-like peptide-1 receptor molecular imagingAnna K Mossman, David A Pattison, Rodney J Hicks, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 14, 2017
<sup>18</sup>F-FDG-Avid Thyroid Incidentalomas: The Importance of Contextual InterpretationDavid A Pattison, Michael Bozin, Alexandra Gorelik, et al.
Journal of Medical Imaging and Radiation Oncology|May 5, 2026
Assessing Correlation of Quantitative Technetium-99m Sestamibi Uptake in Thyroid Scintigraphy With Treatment Duration in Amiodarone-Induced ThyrotoxicosisRay Wang, Nathan Better, Dinesh Sivaratnam, et al.
EJNMMI Research|February 10, 2019
Personalised insulin calculator enables safe and effective correction of hyperglycaemia prior to FDG PET/CTDavid A Pattison, Lisa L MacFarlane, Jason Callahan, et al.
Clinical Nuclear Medicine|July 14, 2022
99m Tc-Sestamibi Thyroid Scintigraphy in Amiodarone-Induced Thyrotoxicosis : Functional Imaging-Histopathologic CorrelationRay Wang, Nathan Better, Dinesh Sivaratnam, et al.
Internal Medicine Journal|December 14, 2020
Utility of <sup>68</sup> Ga-DOTA-Exendin-4 positron emission tomography-computed tomography imaging in distinguishing between insulinoma and nesidioblastosis in patients with confirmed endogenous hyperinsulinaemic hypoglycaemiaVictor Kalff, Amir Iravani, Timothy Akhurst, et al.
Journal of Critical Care|September 15, 2020
Octreotide for resuscitation of cardiac arrest due to carcinoid crisis precipitated by novel peptide receptor radionuclide therapy (PRRT): A case reportJayesh Dhanani, David A Pattison, Matthew Burge, et al.
Nuclear Medicine Communications|January 9, 2015
Quantitative assessment of thyroid-to-background ratio improves the interobserver reliability of technetium-99m sestamibi thyroid scintigraphy for investigation of amiodarone-induced thyrotoxicosisDavid A Pattison, James Westcott, Meir Lichtenstein, et al.
Clinical Case Reports|April 12, 2018
Diagnostic challenges in a patient with an occult insulinoma:<sup>68 </sup>Ga-DOTA-exendin-4 PET/CT and <sup>68</sup>Ga-DOTATATE PET/CTElisa Bongetti, Melissa H Lee, David A Pattison, et al.
Bone Marrow Transplantation|January 23, 2022
[<sup>18</sup>F]GE-180 PET/CT assessment of enterocytic translocator protein (TSPO) over-expression: a pilot study in gastrointestinal GVHDAshleigh P Scott, Paul Thomas, David A Pattison, et al.
Pageof 8